FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to transplantology and clinical laboratory diagnostics; it can be used to diagnose bronchial obstruction in a lung transplant recipient. The concentration of galectin-3 is determined in the venous blood plasma of the lung transplant recipient. If its value is more than 11.7 ng/ml, the presence of bronchial obstruction of the lung transplant is diagnosed.
EFFECT: method provides the possibility of non-invasiveness, reducing the complexity and time of performing, availability of early diagnostics of obstructive bronchial processes in transplanted lungs recipients, while achieving effective diagnostics of bronchial complications in this contingent of patients, as well as increasing its objectivity due to the possibility of making an assessment taking into account the indicator showing the state of the entire transplant – galectin-3, which is secreted in the damaged area and promotes tissue fibrosis.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING BRONCHIAL OBSTRUCTION IN LUNG TRANSPLANT RECIPIENTS | 2020 |
|
RU2750973C1 |
METHOD FOR DIAGNOSING BRONCHIAL OBSTRUCTION IN LUNG TRANSPLANT RECIPIENT | 2020 |
|
RU2760195C1 |
METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS OF TRANSPLANTED HEART AT A LONG POST-TRANSPLANTATION PERIOD IN RECIPIENTS SUFFERING ACUTE REJECTION | 2019 |
|
RU2709193C1 |
METHOD FOR NONINVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS OF CARDIAC ALLOGRAFT | 2021 |
|
RU2772054C1 |
METHOD FOR DIAGNOSING ACUTE REJECTION OF TRANSPLANT IN TRANSPLANTED HEART RECIPIENT | 2020 |
|
RU2758973C1 |
METHOD FOR DIAGNOSING ACUTE TRANSPLANT REJECTION IN TRANSPLANTED HEART RECIPIENTS | 2020 |
|
RU2758994C1 |
METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN CARDIAC TRANSPLANT RECIPIENTS | 2021 |
|
RU2760093C1 |
METHOD FOR PREOPERATIVE PREDICTION OF ACUTE CELLULAR REJECTION OF A TRANSPLANTED HEART | 2022 |
|
RU2798948C1 |
METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN TRANSPLANTED HEART | 2021 |
|
RU2758993C1 |
METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN DONOR HEART RECIPIENTS | 2021 |
|
RU2761470C1 |
Authors
Dates
2021-11-09—Published
2020-11-30—Filed